Literature DB >> 26070574

Aerosolized Surfactants, Anti-Inflammatory Drugs, and Analgesics.

Douglas F Willson1.   

Abstract

Drug delivery by aerosol may have several advantages over other modes, particularly if the lung is the target organ. Aerosol delivery may allow achievement of higher concentrations while minimizing systemic effects and offers convenience, rapid onset of action, and avoidance of the needles and sterile technique necessary with intravenous drug administration. Aerosol delivery may change the pharmacokinetics of many drugs, however, and an awareness of the caveats of aerosolized drug delivery is mandatory to ensure both safety and adequate drug delivery. This paper discusses the administration of surfactants, anti-inflammatory agents, and analgesics by the aerosol route.
Copyright © 2015 by Daedalus Enterprises.

Keywords:  aerosolized surfactants; analgesics; anti-inflammatory agents; drug delivery

Mesh:

Substances:

Year:  2015        PMID: 26070574     DOI: 10.4187/respcare.03579

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  8 in total

Review 1.  Use of computational fluid dynamics deposition modeling in respiratory drug delivery.

Authors:  P Worth Longest; Karl Bass; Rabijit Dutta; Vijaya Rani; Morgan L Thomas; Ahmad El-Achwah; Michael Hindle
Journal:  Expert Opin Drug Deliv       Date:  2018-12-10       Impact factor: 6.648

2.  In Vitro Analysis of Nasal Interface Options for High-Efficiency Aerosol Administration to Preterm Infants.

Authors:  Connor Howe; Mohammad A M Momin; Karl Bass; Ghali Aladwani; Serena Bonasera; Michael Hindle; Philip Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2022-02-14       Impact factor: 3.440

3.  Development of a High-Dose Infant Air-Jet Dry Powder Inhaler (DPI) with Passive Cyclic Loading of the Formulation.

Authors:  Connor Howe; Mohammad A M Momin; Ghali Aladwani; Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2022-10-17       Impact factor: 4.580

4.  Nebulisation of synthetic lamellar lipids mitigates radiation-induced lung injury in a large animal model.

Authors:  David Collie; John T Murchison; Steven H Wright; Alec McLean; Lynsey Howard; Jorge Del-Pozo; Sionagh Smith; Gerry McLachlan; Jessica Lawrence; Elaine Kay; Tobias Schwarz; Magdalena Parys
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

5.  Breath-Synchronized Nebulized Surfactant in a Porcine Model of Acute Respiratory Distress Syndrome.

Authors:  Robert M DiBlasi; Masaki Kajimoto; Jonathan A Poli; Gail Deutsch; Juergen Pfeiffer; Joseph Zimmerman; David N Crotwell; Patrik Malone; James B Fink; Coral Ringer; Rajesh Uthamanthil; Dolena Ledee; Michael A Portman
Journal:  Crit Care Explor       Date:  2021-02-15

Review 6.  Pulmonary surfactant as a versatile biomaterial to fight COVID-19.

Authors:  Lore Herman; Stefaan C De Smedt; Koen Raemdonck
Journal:  J Control Release       Date:  2021-11-20       Impact factor: 9.776

7.  Initial Development of an Air-Jet Dry Powder Inhaler for Rapid Delivery of Pharmaceutical Aerosols to Infants.

Authors:  Connor Howe; Michael Hindle; Serena Bonasera; Vijaya Rani; P Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2020-08-04       Impact factor: 2.849

8.  Design, synthesis, in silico and in vitro antimicrobial screenings of novel 1,2,4-triazoles carrying 1,2,3-triazole scaffold with lipophilic side chain tether.

Authors:  Mohamed Reda Aouad; Mariem Mohammed Mayaba; Arshi Naqvi; Sanaa K Bardaweel; Fawzia Faleh Al-Blewi; Mouslim Messali; Nadjet Rezki
Journal:  Chem Cent J       Date:  2017-11-21       Impact factor: 4.215

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.